Compound Net Biotechnology Inc., established in 2021, is a leading biotechnological enterprise based in Beijing, China. Our company specializes in the research, development, and sales of pharmaceutical intermediates and chemical reagents, boasting an extensive product portfolio of over 10,000 items.

Leveraging advanced AI and computer technologies, we excel in the ultra-fine medicinal chemistry sector. Our innovative approach has enabled us to redesign the synthesis processes for 60,000 existing molecules in China and develop over 40 unique products during our trial phase. This integration of technology and expertise accelerates the discovery and design of new opportunities in the pharmaceutical industry.

Our commitment to excellence is reflected in our rigorous quality assurance, with most of our products achieving purity levels above 97%. We provide comprehensive quality documentation, including NMR spectra and HPLC/GC charts, ensuring the reliability and consistency of our offerings.

At Compound Net Biotechnology Inc., we are not just suppliers but partners in the pharmaceutical industry, dedicated to providing exceptional products and services to drive innovation and development.